Extended-Spectrum β-Lactamase and Carbapenemase Producing Gram-Negative Bacilli Infections Among Patients in Intensive Care Units of Felegehiwot Referral Hospital: A Prospective Cross-Sectional Study

References

• Marshall JC, Bosco L, Adhikari NK, et al. What is an intensive care unit? A report of the task force of the world federation of societies of intensive and critical care medicine. J Crit Care. 2017;37:270–276. doi:10.1016/j.jcrc.2016.07.01527612678
   PubMed Web of Science ®Google Scholar
• Dereli N, Ozayar E, Degerli S, Sahin S, Koç F. Three-year evaluation of nosocomial infection rates of the ICU. Rev Bras Anestesiol. 2013;63(1):79–84. doi:10.1590/S0034-70942013000100006
   Web of Science ®Google Scholar
• Deptuła A, Trejnowska E, Ozorowski T, Hryniewicz W. Risk factors for healthcare-associated infection in light of two years of experience with the ECDC point prevalence survey of healthcare-associated infection and antimicrobial use in Poland. J Hosp Infect. 2015;90(4):310–315. doi:10.1016/j.jhin.2015.03.00525933918
   PubMed Web of Science ®Google Scholar
• Stocchetti N, Carbonara M, Citerio G, et al. Severe traumatic brain injury: targeted management in the intensive care unit. Lancet Neurol. 2017;16(6):452–464. doi:10.1016/S1474-4422(17)30118-728504109
   PubMed Web of Science ®Google Scholar
• Khan HA, Baig FK, Mehboob R. Nosocomial infections: epidemiology, prevention, control and surveillance. Asian Pac J Trop Biomed. 2017;7(5):478–482. doi:10.1016/j.apjtb.2017.01.019
   Web of Science ®Google Scholar
• Agaba P, Tumukunde J, Tindimwebwa JV, Kwizera A. Nosocomial bacterial infections and their antimicrobial susceptibility patterns among patients in Ugandan intensive care units: a cross sectional study. BMC Res Notes. 2017;10(1):349. doi:10.1186/s13104-017-2695-528754148
   PubMedGoogle Scholar
• Akhtar N. Hospital acquired infections in a medical intensive care unit. J Coll Physicians Surg Pak. 2010;20(6):386–390.20642968
   PubMed Web of Science ®Google Scholar
• Kołpa M, Wałaszek M, Gniadek A, Wolak Z, Dobroś W. Incidence, microbiological profile and risk factors of healthcare-associated infections in intensive care units: a 10 year observation in a provincial hospital in Southern Poland. Int J Environ Res Public Health. 2018;15(1):112. doi:10.3390/ijerph15010112
   PubMed Web of Science ®Google Scholar
• Lai CC, Wang CY, Chu CC, et al. Correlation between antibiotic consumption and resistance of Gram-negative bacteria causing healthcare-associated infections at a university hospital in Taiwan from 2000 to 2009. J Antimicrob Chemother. 2011;66(6):1374–1382. doi:10.1093/jac/dkr10321436153
   PubMed Web of Science ®Google Scholar
• Sabir R, Alvi SF, Fawwad A. Antimicrobial susceptibility pattern of aerobic microbial isolates in a clinical laboratory in Karachi-Pakistan. Pak J Med Sci. 2013;29(3):851. doi:10.12669/pjms.293.318724353642
   PubMed Web of Science ®Google Scholar
• Snitkin ES, Zelazny AM, Thomas PJ, et al. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med. 2012;4(148):148ra116. doi:10.1126/scitranslmed.3004129
   PubMed Web of Science ®Google Scholar
• Akova M, Daikos GL, Tzouvelekis L, Carmeli Y. Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria. Clin Microbiol Infect. 2012;18(5):439–448. doi:10.1111/j.1469-0691.2012.03823.x22507111
   PubMed Web of Science ®Google Scholar
• É R, Woerther PL, Barbier F. Mechanisms of antimicrobial resistance in Gram-negative bacilli. Ann Intensive Care. 2015;5(1):21.
   Web of Science ®Google Scholar
• Mehrad B, Clark MN, Zhanel GG, Lynch JP. Antimicrobial resistance in hospital-acquired Gram-Negative bacterial infections. Chest. 2015;147(5):1413–1421. doi:10.1378/chest.14-217125940252
   PubMed Web of Science ®Google Scholar
• Yamachika S, Sugihara C, Kamai Y, Yamashita M. Correlation between penicillin-binding protein 2 mutations and carbapenem resistance in Escherichia coli. J Med Microbiol. 2013;62(3):429–436. doi:10.1099/jmm.0.051631-023222859
   PubMed Web of Science ®Google Scholar
• Nordmann P. Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge. Med Et Maladies Infect. 2014;44(2):51–56. doi:10.1016/j.medmal.2013.11.007
   PubMed Web of Science ®Google Scholar
• Rello J, Eshwara VK, Lagunes L, et al. A global priority list of the top ten resistant microorganisms (TOTEM) study at intensive care: a prioritization exercise based on multi-criteria decision analysis. Eur J Clin Microbiol Infect Dis. 2019;38(2):319–323. doi:10.1007/s10096-018-3428-y30426331
   PubMed Web of Science ®Google Scholar
• Venkatasubramanian P, Balasubramani SP, Patil R. “Planetary Health” perspectives and alternative approaches to tackle the AMR challenge. Antimicrob Resist. 2020;165–188.
   Google Scholar
• Arora A, Jain C, Saxena S, Kaur R. Profile of drug resistant Gram negative bacteria from ICU at a tertiary care center of India. Asian J Med Health. 2017;18:1–7. doi:10.9734/AJMAH/2017/31434
   Google Scholar
• Walia K, Madhumathi J, Veeraraghavan B, et al. Establishing antimicrobial resistance surveillance & research network in India: journey so far. Indian J Med Res. 2019;149(2):164. doi:10.4103/ijmr.IJMR_226_1831219080
   PubMed Web of Science ®Google Scholar
• Cheesbrough M. District Laboratory Practice in Tropical Countries, Part 2. Cambridge university press; 2006.
   Google Scholar
• Zowawi HM, Harris PNA, Roberts MJ, et al. The emerging threat of multidrug-resistant Gram-negative bacteria in urology. Nat Rev Urol. 2015;12(10):570. doi:10.1038/nrurol.2015.19926334085
   PubMed Web of Science ®Google Scholar
• Khushbu Y, Satyam P. Bacteriological profile of lower respiratory tract infection (LRTI) among HIV seropositive cases in Central Terai of Nepal. Int J Curr Microbiol Appl Sci. 2015;4(11):431–442.
   Google Scholar
• Wayne PA. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing. 28th ed. CLSI supplements M 100 2019.
   Google Scholar
• Miller JM, Binnicker MJ, Campbell S, et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis. 2018;67(6):e1–94.29955859
   PubMed Web of Science ®Google Scholar
• Gupta R, Malik A, Rizvi M, Ahmed M. Presence of metallo-beta-lactamases (MBL), extended-spectrum beta-lactamase (ESBL) & AmpC positive non-fermenting Gram-negative bacilli among Intensive Care Unit patients with special reference to molecular detection of blaCTX-M & bla AmpC genes. Indian J Med Res. 2016;144(2):271. doi:10.4103/0971-5916.19504327934808
   PubMed Web of Science ®Google Scholar
• Beyene D, Bitew A, Fantew S, Mihret A, Evans M. Multidrug-resistant profile and prevalence of extended spectrum β-lactamase and carbapenemase production in fermentative Gram-negative bacilli recovered from patients and specimens referred to National Reference Laboratory, Addis Ababa, Ethiopia. PLoS One. 2019;14(9):e0222911. doi:10.1371/journal.pone.022291131553773
   PubMed Web of Science ®Google Scholar
• Uc-Cachón AH, Gracida-Osorno C, Luna-Chi IG, Jiménez-Guillermo JG, Molina-Salinas GM. High prevalence of antimicrobial resistance among Gram-negative isolated bacilli in Intensive Care Units at a Tertiary-Care Hospital in Yucatán Mexico. Med. 2019;55(9):588.
   Google Scholar
• Singh N, Pattnaik D, Neogi DK, Jena J, Mallick B. Prevalence of ESBL in Escherichia coli isolates among ICU patients in a tertiary care hospital. JCDR. 2016;10(9).
   Google Scholar
• Kayastha K, Dhunge B, Karki S, et al. Extended-Spectrum β-Lactamase-producing Escherichia coli and Klebsiella Species in pediatric patients visiting international friendship children’s Hospital, Kathmandu, Nepal. Infect Dis Res Treat. 2020;13:1–7.
   Google Scholar
• Kovacevic P, Zlojutro B, Kovacevic T, Baric G, Dragic S, Momcicevic D. Microorganisms profile and antibiotics sensitivity patterns in the only medical intensive care unit in Bosnia and Herzegovina. Microb Drug Resist. 2019;25(8):1176–1181. doi:10.1089/mdr.2018.045831120362
   PubMed Web of Science ®Google Scholar
• Siddique SG, Bhalchandra MH, Wyawahare AS, Bansal VP, Mishra JK, Naik SD. Prevalence of MRSA, ESBL and Carbapenemase producing isolates obtained from endotracheal and tracheal tubes secretions of ICU patient at tertiary care centre. Int J Curr Microbiol App Sci. 2017;6(4):288–299. doi:10.20546/ijcmas.2017.604.032
   Google Scholar
• Kano CU. Carbapenem-Resistant Enterobacteriaceae (CRE) in Intensive Care Units and surgical wards of hospitals with no history of carbapenem usage in Kano, North West Nigeria. Niger J Microbiol. 2015;27(1):2612–2618.
   Google Scholar
• Moolchandani K, Sastry AS, Deepashree R, Sistla S, Harish BN, Mandal J. Antimicrobial resistance surveillance among Intensive Care Units of a Tertiary Care Hospital in Southern India. J Clin Diagn Res. 2017;11(2):DC01–DC07. doi:10.7860/JCDR/2017/23717.9247
   Web of Science ®Google Scholar
• Pilmis B, Zahar JR. Ventilator-associated pneumonia related to ESBL-producing gram negative bacilli. Ann Transl Med. 2018;6(21):424. doi:10.21037/atm.2018.09.3430581832
   PubMed Web of Science ®Google Scholar
• Sid Ahmed MA, Bansa D, Acharya A, et al. Antimicrobial susceptibility and molecular epidemiology of extended-spectrum beta-lactamase-producing Enterobacteriaceae from intensive care units at Hamad Medical Corporation, Qatar. Antimicrob Resist Infect Control. 2016;5:4. doi:10.1186/s13756-016-0103-x26865975
   PubMed Web of Science ®Google Scholar
• Oberoi L, Singh N, Sharma P, Aggarwal A. ESBL, MBL and Ampc β lactamases producing superbugs–Havoc in the Intensive Care Units of Punjab India. JCDR. 2013;7(1):70. doi:10.7860/JCDR/2012/5016.267323450498
   PubMedGoogle Scholar
• Saeed NK, Kambal AM, El-Khizzi NA. Antimicrobial-resistant bacteria in a general intensive care unit in Saudi Arabia. Saudi Med J. 2010;31(12):1341–1349.21135998
   PubMed Web of Science ®Google Scholar
• Saharman YR, Lestari DC. Phenotype characterization of beta-lactamase producing enterobacteriaceae in the intensive care unit (ICU) of CiptoMangunkusumo hospital in 2011. Acta Med Indonesiana. 2016;45(1).
   Google Scholar
• Hecini-Hannachi A, Bentchouala C, Lezzar A, et al. Multidrug-resistant bacteria isolated from patients hospitalized in Intensive Care Unit in University Hospital of Constantine, Algeria. Afr J Microbiol Res. 2016;10(33):1328–1336. doi:10.5897/AJMR2016.8257
   Google Scholar
• Leite CA, Oizumi KY, Caleffi-Ferracioli KR, et al. β - lactamase producing Gram-negative bacteria in an intensive care unit in southern Brazil. Brazilian J Pharm Sci. 2017;53(2).
   Web of Science ®Google Scholar
• Shrestha UT, Shrestha S, Adhikari N, et al. Plasmid profiling and occurrence of β-lactamase enzymes in multidrug-resistant uropathogenic Escherichia coli in Kathmandu, Nepal. Infect Drug Resist. 2020;13.
   Web of Science ®Google Scholar
• Chang YY, Chuang YC, Siu LK, et al. Clinical features of patients with carbapenem non-susceptible Klebsiella pneumoniae and Escherichia coli in intensive care units: a nationwide multicenter study in Taiwan. J Microbiol Immunol Infect. 2015;48(2):219–225. doi:10.1016/j.jmii.2014.05.01025074627
   PubMedGoogle Scholar
• Zaha DC, Kiss R, Hegedűs C, et al. Recent advances in investigation, prevention, and management of healthcare-associated infections (HAIs): resistant multidrug strain colonization and its risk factors in an Intensive Care Unit of a University Hospital. Biomed Res Int. 2019;2019:2019. doi:10.1155/2019/2510875
   Web of Science ®Google Scholar
• Liao CH, Lee NY, Tang HJ, et al. Antimicrobial activities of ceftazidime-avibactam, ceftolozane- tazobactam, and other agents against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa isolated from intensive care units in Taiwan: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan in 2016. Infect Drug Resist. 2019;12:545. doi:10.2147/IDR.S19363830881060
   PubMed Web of Science ®Google Scholar
• Muktan B, Shrestha UT, Dhungel B, et al. Plasmid mediated colistin resistant mcr-1 and co-existence of OXA-48 among Escherichia coli from clinical and poultry isolates: first report from Nepal. Gut Pathog. 2020;12:44. doi:10.1186/s13099-020-00382-532963589
   PubMed Web of Science ®Google Scholar
• Daef EA, Elsherbiny NM. Clinical and microbiological profile of nosocomial infections in adult intensive care units at Assiut University hospitals, Egypt. J Am Sci. 2012;8(12):1239–1250.
   Google Scholar
• Wilson J. Surgical site infection: the principles and practice of surveillance. Part 1: key concepts in the methodology of SSI surveillance. J Infect Prev. 2013;14(1):6–12. doi:10.1177/1757177412471147
   Google Scholar